Browse > Article
http://dx.doi.org/10.5352/JLS.2006.16.2.328

Inhibitory Effect of Thujae orientalis Semen Extract on Pancreatic Lipase Activity  

Kim Min-Soo (Korea Research Institute of Bioscience and Biotechnology)
Kim Bo-Yeon (Korea Research Institute of Bioscience and Biotechnology)
Park Chan-Sun (Korea Research Institute of Bioscience and Biotechnology)
Yoon Byung-Dae (Korea Research Institute of Bioscience and Biotechnology)
Ahn Soon-Cheol (Department of Microbiology and Immunology, College of Medicine, Pusan National University)
Oh Won-Keun (Korea Research Institute of Bioscience and Biotechnology)
Ahn Jong-Seog (Korea Research Institute of Bioscience and Biotechnology)
Publication Information
Journal of Life Science / v.16, no.2, 2006 , pp. 328-332 More about this Journal
Abstract
The possible presence of inhibitors of pancreatic lipase (tricaylglycerol acylhydrolase EC 3.1.1.3) was screened from Korean traditional edible or medicinal herbs. Among tested herbs, Arecae pericarpium, Mucunae Caulis, Rhus javanica, Thujae orientalis were shown to have strong inhibitory effect against pancreatic lipase. Thujae orientalis was finally selected as a candidate for pancreatic lipase inhibitor. The extract of Thujae orientalis was showed selective inhibition on porcine pancreatic lipase activity. Active inhibitors, TF-1, TF-2, TF-3, were purified from an extract of Thujae orientalis, using chloroform extraction, followed by successive chromatography in silica gel and LH-20 and high performance liquid chromatography (HPLC). The $IC_{50}$ values of TF-1, TF-2, TF-3 and orlistat were 44.7, 98.7, 46.1 and $27.6{\mu}g/ml$, respectively. And also the TF-2 and orlistat were shown to be inhibitory effect on the differentiation of preadipocyte NIH-3T3 L1 cells at a concentration of $10{\mu}g/ml$.
Keywords
Pancreatic lipase inhibitor; Thujae orientalis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Shimura, S., W. Tsuzuki, Y. Itho S. kobayashi and T. Suzuki. 1994. Inhibitory effect of tannin fraction Cassia mimosoides L. var. nomame makino on lipase activity. Nippon Shokuhin Kogyo Gakkaishi. 41, 561-564   DOI   ScienceOn
2 Flegal, K. M., M. D. Carroll, C. L. Ogden, and C. L. Johnson. 2002. Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA. 288, 1723-1727   DOI   ScienceOn
3 Freedman, D. S., M. K. Serdula, C. A. Perey and L. Whitle. 1997. Obesity levels of lipids and glucose, and smoking among Navajo adolescents. J. Nutr. 127, 2120S-2127S
4 Larsson, B., P. Bjorntorp and G. Tibblin. 1981. The health consequences of moderate obesity. Int. J. Obes. Relat. Metab. Disord. 5, 97-106
5 Peter, C. and G. Williams. 2001. Drug treatment of obesity: from past failures to future successes?. Br. J. Clin. Pharmacol. 51, 135-141
6 보건복지부. 2002. 2001년 국민영양조사
7 Yamamoto, M., S. Shimura, Y. Iyoh, M. Egawa and S. Ionue. 2000. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int. J. Obesity 24, 758-764   DOI   ScienceOn
8 Zapf, J., E. W. Schoenole, M. Waldvogel, M. Sand and E. R. Froesch. 1981. Effect of trypsin treatment of rat adipocyte on biological effects and binding of insulin and insulin- like growth factors : Further evidence for the action of insulin-like growth factors through the insulin receptor. Eur. J. Biochem. 133, 605-609
9 Rexrode, K. M., J. E. Manson and C. H. Hennekens. 1996. Obesity and cardiovascular disease. Curr. Opin. Cardiol. 11, 490-495   DOI
10 Sjostrom, L., A. Rissanen, T. Andersen, M. Boldrin, A. Golay and H. P. F. Koppeschaar. 1998. Randomised placebo- controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 352, 167 -172   DOI   ScienceOn
11 Taylor, C. B., S. P. Fortman, J. Flora, S. Kayman, D. C. Barrett, D. Jatulis and J. W. Farghar. 1991. Effect of long term community health education on body mass index. Am. J. Epidemiol. 134, 235-249   DOI
12 Wada, K. and Y. Ikeda. 1998. Longitudinal studies to determine the effect of body fat rate reduction on blood pressure. J. Med. Syst. 22, 19-25   DOI   ScienceOn
13 World Health Organization Consultation on Obesity. 1998. Obesity: Preventing and Managing the Global Epidemic. World Health Organization: Geneva
14 Bitou, N., M. Nimomiya, T. Tsjita and H. Okuda. 1999. Screening of lipase inhibitors from marine algae. Lipids 34, 441-445   DOI   ScienceOn
15 Hauptman, J. B., F. S. Jeunet and D. Hartmann. 1992. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647(tetrahydrolipstatin). Am. J. Clin. Nutr. 55, 309S -313S   DOI
16 Alberti, K. G. and P. Z. Zimmet. 1988. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 13, 539-353
17 Borgstom, B. 1986. Luminal digestion of fat. pp. 361-373. In Go I(ed.). The exocrine pancreas : biology, pathobiology, and disease. Raven Press, New York
18 Bray, G. A. and B. M. Popkin. 1998. Dietary fat intake dose affect obesity. Am. J. Clin. Nutr. 68, 1157-1173   DOI
19 Bray, G. A. and B. M. Popkin. 1999. Dietary fat affects obesity rate. Am. J. Clin. Nutr. 70, 572-573   DOI
20 Diehl, A. K. 1991. Epidemiology and natural history of gallstone disease. Gastroenterol. Clin. N. Am. 20, 1-19
21 Drent, M. L., I. Larsson, T. William-Olsson, F. Quaade, F. Czubayko, K. Von Bergmann, W. Strobel, L. Sjotro and E. A. Van der Veen. 1995. Orlistat (RO 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int. J. Obes. 19, 221 -226
22 Grundy, S. M. 1999. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83, 25F -29F   DOI   ScienceOn
23 Hadvay, P., H. Lengsfeld and H. Wolter. 1988. Inhibition of pancreatic lipase in vitro by covalent inhibitor tetrahydrolipstatin. Biochem. J. 256, 357-361   DOI